Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients

• Published in: Liver transplantation Vol. 20; no. 6; pp. 679 - 686
• Main Authors: Venkat, Veena L., Ranganathan, Sarangarajan, Mazariegos, George V., Sun, Qing, Sindhi, Rakesh
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.06.2014
• Subjects: Adolescent; Age Factors; Antilymphocyte Serum - therapeutic use; Biopsy; Child; Child, Preschool; Cholangitis, Sclerosing - diagnosis; Cholangitis, Sclerosing - immunology; Cholangitis, Sclerosing - mortality; Cholangitis, Sclerosing - surgery; Fatal Outcome; Female; Graft Survival; Humans; Immunosuppressive Agents - therapeutic use; Liver Transplantation - adverse effects; Liver Transplantation - mortality; Male; Pennsylvania; Recurrence; Retrospective Studies; Risk Factors; Steroids - therapeutic use; Tacrolimus - therapeutic use; Time Factors; Treatment Outcome

There is little detailed clinical information on recurrent primary sclerosing cholangitis (rPSC) after liver transplantation in children. Our purpose was to describe the characteristics of children who had experienced rPSC after liver transplantation so that we could identify potential risk factors...